Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam GB, Sacher F, Shimizu W, Viskin S, Wilde AA.

J Arrhythm. 2016 Oct;32(5):315-339. No abstract available.

PMID:
27761155
2.

J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam GB, Sacher F, Shimizu W, Viskin S, Wilde AA.

Heart Rhythm. 2016 Oct;13(10):e295-324. doi: 10.1016/j.hrthm.2016.05.024. Review. No abstract available.

PMID:
27423412
3.

Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.

Veltmann C, Barajas-Martinez H, Wolpert C, Borggrefe M, Schimpf R, Pfeiffer R, Cáceres G, Burashnikov E, Antzelevitch C, Hu D.

J Am Heart Assoc. 2016 Jul 5;5(7). pii: e003379. doi: 10.1161/JAHA.116.003379.

PMID:
27381756
4.

RyR2 QQ2958 Genotype and Risk of Malignant Ventricular Arrhythmias.

Galati F, Galati A, Massari S.

Cardiol Res Pract. 2016;2016:2868604. doi: 10.1155/2016/2868604.

PMID:
26904356
5.

A new look at sodium channel β subunits.

Namadurai S, Yereddi NR, Cusdin FS, Huang CL, Chirgadze DY, Jackson AP.

Open Biol. 2015 Jan;5(1):140192. doi: 10.1098/rsob.140192. Review.

PMID:
25567098
6.

Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome.

Juang JM, Lu TP, Lai LC, Ho CC, Liu YB, Tsai CT, Lin LY, Yu CC, Chen WJ, Chiang FT, Yeh SF, Lai LP, Chuang EY, Lin JL.

Sci Rep. 2014 Oct 23;4:6733. doi: 10.1038/srep06733.

PMID:
25339316
7.

Gain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder.

Friedrich C, Rinné S, Zumhagen S, Kiper AK, Silbernagel N, Netter MF, Stallmeyer B, Schulze-Bahr E, Decher N.

EMBO Mol Med. 2014 Jun 27;6(7):937-51. doi: 10.15252/emmm.201303783.

PMID:
24972929
8.

Reduced Penetrance and Variable Expression of SCN5A Mutations and the Importance of Co-inherited Genetic Variants: Case Report and Review of the Literature.

Robyns T, Nuyens D, Van Casteren L, Corveleyn A, De Ravel T, Heidbuchel H, Willems R.

Indian Pacing Electrophysiol J. 2014 May 25;14(3):133-49.

PMID:
24948852
9.

Brugada syndrome risk loci seem protective against atrial fibrillation.

Andreasen L, Nielsen JB, Darkner S, Christophersen IE, Jabbari J, Refsgaard L, Thiis JJ, Sajadieh A, Tveit A, Haunsø S, Svendsen JH, Schmitt N, Olesen MS.

Eur J Hum Genet. 2014 Dec;22(12):1357-61. doi: 10.1038/ejhg.2014.46.

PMID:
24667784
10.

Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.

Hoshi M, Du XX, Shinlapawittayatorn K, Liu H, Chai S, Wan X, Ficker E, Deschênes I.

Circ Cardiovasc Genet. 2014 Apr;7(2):123-31. doi: 10.1161/CIRCGENETICS.113.000292.

PMID:
24573164
11.

Utilizing multiple in silico analyses to identify putative causal SCN5A variants in Brugada syndrome.

Juang JM, Lu TP, Lai LC, Hsueh CH, Liu YB, Tsai CT, Lin LY, Yu CC, Hwang JJ, Chiang FT, Yeh SS, Chen WP, Chuang EY, Lai LP, Lin JL.

Sci Rep. 2014 Jan 27;4:3850. doi: 10.1038/srep03850.

PMID:
24463578
12.

PATH-SCAN: a reporting tool for identifying clinically actionable variants.

Daneshjou R, Zappala Z, Kukurba K, Boyle SM, Ormond KE, Klein TE, Snyder M, Bustamante CD, Altman RB, Montgomery SB.

Pac Symp Biocomput. 2014:229-40.

PMID:
24297550
13.

Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification.

Sommariva E, Pappone C, Martinelli Boneschi F, Di Resta C, Rosaria Carbone M, Salvi E, Vergara P, Sala S, Cusi D, Ferrari M, Benedetti S.

Eur J Hum Genet. 2013 Sep;21(9):911-7. doi: 10.1038/ejhg.2012.289.

PMID:
23321620
14.

Molecular and genetic basis of sudden cardiac death.

George AL Jr.

J Clin Invest. 2013 Jan;123(1):75-83. doi: 10.1172/JCI62928. Review.

PMID:
23281413
15.

The β1-subunit of Na(v)1.5 cardiac sodium channel is required for a dominant negative effect through α-α interaction.

Mercier A, Clément R, Harnois T, Bourmeyster N, Faivre JF, Findlay I, Chahine M, Bois P, Chatelier A.

PLoS One. 2012;7(11):e48690. doi: 10.1371/journal.pone.0048690.

PMID:
23133651
16.

Dominant-negative effect of SCN5A N-terminal mutations through the interaction of Na(v)1.5 α-subunits.

Clatot J, Ziyadeh-Isleem A, Maugenre S, Denjoy I, Liu H, Dilanian G, Hatem SN, Deschênes I, Coulombe A, Guicheney P, Neyroud N.

Cardiovasc Res. 2012 Oct 1;96(1):53-63. doi: 10.1093/cvr/cvs211.

PMID:
22739120
17.

Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia.

Murphy LL, Moon-Grady AJ, Cuneo BF, Wakai RT, Yu S, Kunic JD, Benson DW, George AL Jr.

Heart Rhythm. 2012 Apr;9(4):590-7. doi: 10.1016/j.hrthm.2011.11.006.

PMID:
22064211
18.

A novel frequency analysis method for assessing K(ir)2.1 and Na (v)1.5 currents.

Rigby JR, Poelzing S.

Ann Biomed Eng. 2012 Apr;40(4):946-54. doi: 10.1007/s10439-011-0460-9.

PMID:
22052157
19.

Defining the disconnect between in vitro models and human arrhythmogenic disease: context matters.

Sturm AC, Mohler PJ.

Circulation. 2011 Aug 30;124(9):993-5. doi: 10.1161/CIRCULATIONAHA.111.051466. No abstract available.

PMID:
21875919
20.

A novel strategy using cardiac sodium channel polymorphic fragments to rescue trafficking-deficient SCN5A mutations.

Shinlapawittayatorn K, Dudash LA, Du XX, Heller L, Poelzing S, Ficker E, Deschênes I.

Circ Cardiovasc Genet. 2011 Oct;4(5):500-9. doi: 10.1161/CIRCGENETICS.111.960633.

PMID:
21840964
Items per page

Supplemental Content

Support Center